Cover Image
市場調查報告書

美國的自體免疫疾病 (AID) 診斷市場分析

Analysis of the US Autoimmune Disease Diagnostics Market

出版商 Frost & Sullivan 商品編碼 353917
出版日期 內容資訊 英文 59 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的自體免疫疾病 (AID) 診斷市場分析 Analysis of the US Autoimmune Disease Diagnostics Market
出版日期: 2016年02月24日 內容資訊: 英文 59 Pages
簡介

根據國立衛生研究所 (NIH) ,自體免疫疾病 (AID) 有80種以上,其中,不滿30種可診斷。

本報告提供美國的自體免疫疾病 (AID) 診斷市場相關調查分析,市場概要,競爭概要,成長機會,各市場區隔分析等系統性資訊。

摘要整理

競爭概要

  • AID診斷市場生態系統
  • AID診斷市場重要性
  • AID診斷市場重要性:盛行率
  • 競爭情形
  • 主要的疾病和美國市場可利用的解決方案
  • LDT:AID診斷所扮演的角色
  • 市場區隔生命週期分析:各疾病
  • 整體市場的預測
  • 疾病整體市場區隔佔有率
  • 競爭SWOT分析:各企業

成長機會

  • 市場機會在哪裡
  • 製藥公司和診斷商務的整合
  • 自體免疫診斷企業與製藥合併,多樣化收益流通管道
  • 消費者的直銷市場:風險與機會

局部性疾病診斷市場區隔

  • 收益
  • 成長率
  • 競爭矩陣
  • 自體免疫檢驗

全身性疾病診斷市場區隔

  • 收益
  • 成長率
  • 競爭矩陣
  • 自體免疫檢驗

結論

附錄

關於Frost&Sullivan

目錄
Product Code: 9AB9-00-48-00-00

Systemic Autoimmune Diseases Spur a Double-digit Market Growth Rate of 14.2%

According to the National Institute of Health (NIH), there are more than 80 types of autoimmune diseases, of which less than 30 are diagnosable. Being 1 of the top 10 causes of death in the United States, there is a critical need in the market for the diagnosis and the treatment of both systemic diseases, such as lupus and rheumatoid arthritis, as well as localized diseases, such as celiac, IBD, IBS, and Hashimoto's. Systemic diseases dominate the market due to their high prevalence in the United States and also because of the market participation of large diagnostics companies, such as Inova Diagnostics, Siemens Healthcare, Abbott Diagnostics, and Beckman Coulter. The localized disease segment is the fastest-growing, mainly due to celiac, as gluten intolerance in the United States is increasing at an exponential rate.

Table of Contents

Executive Summary

  • 1. Scope and Segmentation
  • 2. Key Predictions: US Autoimmune Disease Diagnostics Market
  • 3. Current Trends in the Autoimmune Disease Diagnostics Market
  • 4. Autoimmune Disease Diagnostics Market-Overview
  • 5. Key Companies to Watch

Competitive Overview

  • 1. Ecosystem of the Autoimmune Disease Diagnostics Market
  • 2. Significance of the Autoimmune Disease Diagnostics Market
  • 3. Significance of the Autoimmune Disease Diagnostics Market-Prevalence Rates
  • 4. Competitive Landscape
  • 5. Key Diseases and Available Solutions in the US Market
  • 6. Key Diseases and Available Solutions in the US Market (continued)
  • 7. LDTs-Role in Autoimmune Disease Diagnostics
  • 8. Segment Lifecycle Analysis by Disease
  • 9. Overall Market Forecast
  • 10. Overall Disease Segment Share
  • 11. Competitive SWOT Analysis by Company
  • 12. Competitive SWOT Analysis by Company (continued)

Growth Opportunities

  • 1. Where do the Opportunities Lie in this Market?
  • 2. Pharma and Diagnostics Business Integration
  • 3. Autoimmune Diagnostics Companies are Uniting with Pharmaceuticals to Diversify Revenue Channels
  • 4. Direct-to-Consumer Market: The Risk and The Opportunity

Localized Disease Diagnostics Segment

  • 1. Localized Disease Diagnostics Segment Revenue
  • 2. Growth Rate by Localized Autoimmune Diseases
  • 3. Competitive Value Matrix-Localized Disease Diagnostics Segment
  • 4. Autoimmune Tests-Role in Patient Continuum

Systemic Disease Diagnostics Segment

  • 1. Systemic Disease Diagnostics Segment Revenue
  • 2. Growth Rate by Systemic Autoimmune Diseases
  • 3. Competitive Value Matrix-Systemic Disease Diagnostics Segment
  • 4. Autoimmune Tests-Role in Patient Continuum

Conclusion

  • 1. Key Conclusions and Future Outlook
  • 2. Legal Disclaimer

Appendix-List of LDTs

  • 1. Celiac Disease-specific LDT Assays
  • 2. Chron's Disease-specific LDT Assays
  • 3. RA-specific LDT Assays
  • 4. Lupus-specific LDT Assays
  • 5. IBD/IBS-specific LDT Assays
  • 6. Others
  • 7. Learn More-Next Steps
  • 8. List of Exhibits
  • 9. List of Exhibits (continued)
  • 10. List of Exhibits (continued)

The Frost & Sullivan Story

  • 1. The Frost & Sullivan Story
  • 2. Value Proposition: Future of Your Company & Career
  • 3. Global Perspective
  • 4. Industry Convergence
  • 5. 360° Research Perspective
  • 6. Implementation Excellence
  • 7. Our Blue Ocean Strategy
Back to Top